Case number 1:20-cv-00318
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 19, 2022 | N/A | Terminated Case (0) Docket Text: CASES CLOSED per the CONSENT JUDGMENT AND PERMANENT INJUNCTION FILED IN CIV. NO. 18-651-CFC. Associated Cases: 1:19-cv-00926-CFC, 1:20-cv-00235-CFC, 1:20-cv-00318-CFC, 1:20-cv-01334-CFC, 1:21-cv-00283-CFC(nmf) |
| May 5, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO 18-651-CFC ONLY. (nmf) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 19 in 1:19-cv-00560-CFC, 20 in 1:19-cv-00685-CFC) Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc., (20 in 1:20-cv-00235-CFC, 129 in 1:18-cv-00651-CFC, 25 in 1:19-cv-02202-CFC, 133 in 1:18-cv-00690-CFC, 21 in 1:20-cv-00093-CFC, 132 in 1:18-cv-00689-CFC, 20 in 1:20-cv-00083-CFC, 23 in 1:19-cv-02375-CFC, 18 in 1:20-cv-00318-CFC) Stipulation filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| Apr 21, 2020 | 18 | Stipulation (4) Docket Text: Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 17, 2020 | 17 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Disclosure of Accused Products and the Asserted Patents filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Apr 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin E. Warner for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00318-CFC, 1:20-cv-00235-CFC(kmd) |
| Apr 13, 2020 | 16 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Vanda Pharmaceuticals Inc.s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Apr 10, 2020 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Apr 2, 2020 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 4/2/2020. (Court Reporter V. Gunning.) Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Apr 2, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:19-cv-02202-CFC et al.(cak) |
| Apr 2, 2020 | 14 | Scheduling Order (26) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/14/2020. Amended Pleadings due by 8/14/2020. Fact Discovery completed by 11/20/2020. Expert Discovery due by 4/30/2021. Dispositive Motions due by 5/21/2021. Joint Claim Construction Brief due by 8/7/2020. A Markman Hearing is set for 8/19/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 6/9/2021. A Final Pretrial Conference is set for 6/30/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 7/19/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/2/2020. Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Apr 1, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00318-CFC, 1:20-cv-00235-CFC(mal) |
| Apr 1, 2020 | 13 | Answer to Counterclaim (10) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Mar 31, 2020 | 11 | Certification of Bryce A. Cooper (1) |
| Mar 31, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner and Bryce A. Cooper filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/31/2020. (fms) |
| Mar 31, 2020 | 11 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner and Bryce A. Cooper - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Kevin E. Warner, # (2) Certification of Bryce A. Cooper)(Bilson, David) |
| Mar 31, 2020 | 11 | Certification of Kevin E. Warner (1) |
| Mar 31, 2020 | 12 | Main Document (26) Docket Text: PROPOSED ORDER Joint Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) K. Jacobs cover letter to Judge Connolly)(Jacobs, Karen) |
| Mar 31, 2020 | 12 | K. Jacobs cover letter to Judge Connolly (2) |
| Mar 13, 2020 | 9 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, , Affirmative Defenses and, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Phillips, John) |
| Mar 13, 2020 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Pharmaceuticals Inc.. (Phillips, John) |
| Mar 12, 2020 | 8 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/2/2020 at 03:30 PM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about scheduling, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/12/2020. Associated Cases: 1:19-cv-02202-CFC et al.(nmf) |
| Mar 11, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Mar 4, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 3/4/2020, answer due 3/25/2020. (Jacobs, Karen) |
| Mar 4, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Laboratories Private Limited served on 3/4/2020, answer due 3/25/2020. (Jacobs, Karen) |
| Mar 3, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Limited on 3/3/2020; MSN Pharmaceuticals Inc. on 3/3/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mal) |
| Mar 3, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (mal) |
| Mar 3, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,449,176. (mal) |
| Mar 3, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/10/2020. Date of Expiration of Patent: 01/25/2033.Thirty Month Stay Deadline: 7/31/2021. (mal) |
| Mar 3, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Mar 3, 2020 | 1 | Civil Cover Sheet (1) |
| Mar 3, 2020 | 1 | Exhibit A (37) |
| Mar 3, 2020 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2868662.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(mal) |
| Mar 3, 2020 | 1 | Complaint* (1) |
